Interventions to ameliorate reductions in muscle quantity and function in hospitalised older adults: a systematic review towards acute sarcopenia treatment
- PMID: 33098419
- PMCID: PMC7936029
- DOI: 10.1093/ageing/afaa209
Interventions to ameliorate reductions in muscle quantity and function in hospitalised older adults: a systematic review towards acute sarcopenia treatment
Abstract
Objective: Assimilate evidence for interventions to ameliorate negative changes in physical performance, muscle strength and muscle quantity in hospitalised older adults.
Methods: We searched for articles using MEDLINE, Embase, CINAHL and Cochrane library using terms for randomised controlled trials, older adults, hospitalisation and change in muscle quantity, strength or physical performance. Two independent reviewers extracted data and assessed risk of bias. We calculated standardised mean differences for changes in muscle function/quantity pre- and post-intervention.
Results: We identified 9,805 articles; 9,614 were excluded on title/abstract; 147 full texts were excluded. We included 44 studies including 4,522 participants; mean age 79.1. Twenty-seven studies (n = 3,417) involved physical activity interventions; a variety were trialled. Eleven studies involved nutritional interventions (n = 676). One trial involved testosterone (n = 39), two involved Growth Hormone (n = 53), one involved nandrolone (n = 29), and another involved erythropoietin (n = 141). Three studies (n = 206) tested Neuromuscular Electrical Stimulation. Evidence for effectiveness/efficacy was limited. Strongest evidence was for multi-component physical activity interventions. However, all studies exhibited at least some concerns for overall risk of bias, and considering inconsistencies of effect sizes across studies, certainty around true effect sizes is limited.
Conclusion: There is currently insufficient evidence for effective interventions to ameliorate changes in muscle function/quantity in hospitalised older adults. Multiple interventions have been safely trialled in heterogeneous populations across different settings. Treatment may need to be stratified to individual need. Larger scale studies testing combinations of interventions are warranted. Research aimed at understanding pathophysiology of acute sarcopenia will enable careful risk stratification and targeted interventions.
Keywords: acute sarcopenia; interventions; older people; systematic review.
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Geriatrics Society.
Figures
Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Protocol for understanding acute sarcopenia: a cohort study to characterise changes in muscle quantity and physical function in older adults following hospitalisation.BMC Geriatr. 2020 Jul 10;20(1):239. doi: 10.1186/s12877-020-01626-4. BMC Geriatr. 2020. PMID: 32650734 Free PMC article.
-
Nutrition interventions implemented in hospital to lower risk of sarcopenia in older adults: A systematic review of randomised controlled trials.Nutr Diet. 2020 Feb;77(1):90-102. doi: 10.1111/1747-0080.12608. Nutr Diet. 2020. PMID: 32022999 Free PMC article.
-
Effects of exercise on muscle mass, strength, and physical performance in older adults with sarcopenia: A systematic review and meta-analysis according to the EWGSOP criteria.Exp Gerontol. 2021 Aug;151:111420. doi: 10.1016/j.exger.2021.111420. Epub 2021 May 23. Exp Gerontol. 2021. PMID: 34029642
-
The effect of animal versus plant protein on muscle mass, muscle strength, physical performance and sarcopenia in adults: protocol for a systematic review.Syst Rev. 2022 Apr 13;11(1):64. doi: 10.1186/s13643-022-01951-2. Syst Rev. 2022. PMID: 35418173 Free PMC article.
Cited by
-
New horizons in hospital-associated deconditioning: a global condition of body and mind.Age Ageing. 2024 Nov 1;53(11):afae241. doi: 10.1093/ageing/afae241. Age Ageing. 2024. PMID: 39497271 Free PMC article. Review.
-
An Economic Cost Analysis of Implementing a Frailty Care Bundle to Reduce Risk of Hospital Associated Decline Among Older Patients.J Frailty Sarcopenia Falls. 2024 Sep 1;9(3):218-226. doi: 10.22540/JFSF-09-218. eCollection 2024 Sep. J Frailty Sarcopenia Falls. 2024. PMID: 39228668 Free PMC article.
-
The Validity of Muscle Ultrasound in the Diagnostic Workup of Sarcopenia Among Older Adults: A Scoping Review.Clin Interv Aging. 2024 May 30;19:993-1003. doi: 10.2147/CIA.S463917. eCollection 2024. Clin Interv Aging. 2024. PMID: 38831963 Free PMC article.
-
Acute Sarcopenia: Mechanisms and Management.Nutrients. 2024 Oct 10;16(20):3428. doi: 10.3390/nu16203428. Nutrients. 2024. PMID: 39458423 Free PMC article. Review.
-
Short-Term Multicomponent Exercise Impact on Muscle Function and Structure in Hospitalized Older at Risk of Acute Sarcopenia.J Cachexia Sarcopenia Muscle. 2024 Dec;15(6):2586-2594. doi: 10.1002/jcsm.13602. Epub 2024 Oct 13. J Cachexia Sarcopenia Muscle. 2024. PMID: 39400535 Free PMC article. Clinical Trial.
References
-
- Cruz-Jentoft AJ, Sayer AA. Sarcopenia. The Lancet 2019;393:2636–46. - PubMed
-
- Yoshimura Y, Wakabayashi H, Yamada M, Kim H, Harada A, Arai H. Interventions for treating sarcopenia: a systematic review and meta-analysis of randomized controlled studies. J Am Med Dir Assoc. 2017;18:553.e1-.e16. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical